MARINUS PHARMACEUTICALS, INC. Patent Applications Rejected
12 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2023-09-21: Application 18472048; Invention Intravenous Ganaxolone Formulations and Methods of Use in Treating Status Epilepticus and Other Seizure Disorders; Applicant MARINUS PHARMACEUTICALS, INC.; Status Abandoned -- Failure to Respond to an Office Action.
- 2023-08-28: Application 18456719; Invention GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS; Applicant Marinus Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2023-08-04: Application 18365280; Invention GANAXOLONE FOR USE IN TREATING GENETIC EPILEPTIC DISORDERS; Applicant Marinus Pharmaceuticals, Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
- 2023-07-20: Application 18355684; Invention AMORPHOUS SOLID DISPERSION GANAXOLONE FORMULATION; Applicant MARINUS PHARMACEUTICALS, INC.; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2023-09-21 | 18472048 | Intravenous Ganaxolone Formulations and Methods of Use in Treating Status Epilepticus and Other Seizure Disorders | MARINUS PHARMACEUTICALS, INC. | Abandoned -- Failure to Respond to an Office Action | US20240016817A1 | Mingbao ZHANG Raymond C. GLOWAKY | United States United States | JIANG, SHAOJIA A |
| 2023-08-28 | 18456719 | GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS | Marinus Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20230405021A1 | David CZEKAI Maciej GASIOR Lorianne MASUOKA Julia TSAI Joseph HULIHAN Alex AIMETTI | United States United States United States United States United States United States | AZPURU, CARLOS A |
| 2023-08-04 | 18365280 | GANAXOLONE FOR USE IN TREATING GENETIC EPILEPTIC DISORDERS | Marinus Pharmaceuticals, Inc. | Abandoned -- Incomplete Application (Pre-examination) | Lorianne K. Masuoka Jaakko Lappalainen | United States United States | ||
| 2023-07-20 | 18355684 | AMORPHOUS SOLID DISPERSION GANAXOLONE FORMULATION | MARINUS PHARMACEUTICALS, INC. | Abandoned -- Failure to Respond to an Office Action | US20230390305A1 | David CZEKAI Vinod TULIANI Michael SAPORITO | United States United States United States | BROWE, DAVID |
| 2023-03-28 | 18191445 | INTRAVENOUS GANAXOLONE FORMULATIONS AND METHODS OF USE IN TREATING STATUS EPILEPTICUS AND OTHER SEIZURE DISORDERS | MARINUS PHARMACEUTICALS, INC. | Abandoned -- Failure to Respond to an Office Action | US20230293549A1 | Mingbao ZHANG Raymond C. Glowaky | United States United States | CRAIGO, BAHAR ALAWI |
| 2023-02-10 | 18167281 | Intravenous Ganaxolone Formulations and Methods of Use in Treating Status Epilepticus and Other Seizure Disorders | MARINUS PHARMACEUTICALS, INC. | Abandoned -- Incomplete Application (Pre-examination) | Mingbao ZHANG Raymond C. GLOWAKY | United States United States | ||
| 2022-06-30 | 17854448 | Intravenous Ganaxolone Formulations and Methods of Use in Treating Status Epilepticus and Other Seizure Disorders | MARINUS PHARMACEUTICALS, INC. | Abandoned -- Incomplete Application (Pre-examination) | Mingbao ZHANG Raymond C. GLOWAKY | United States United States | ||
| 2022-06-30 | 17854437 | INJECTABLE NEUROSTEROID FORMULATIONS CONTAINING NANOPARTICLES | MARINUS PHARMACEUTICALS, INC. | Abandoned -- Incomplete Application (Pre-examination) | Mingbao ZHANG Raymond C. GLOWAKY David CZEKAI | United States United States United States | ||
| 2022-03-24 | 17703331 | GANAXOLONE FOR USE IN TREATING GENETIC EPILEPTIC DISORDERS | Marinus Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20220249515A1 | Lorianne K. Masuoka Jaakko Lappalainen | United States United States | BADIO, BARBARA P |
| 2022-02-25 | 17681001 | GANAXOLONE FOR USE IN TREATING GENETIC EPILEPTIC DISORDERS | Marinus Pharmaceuticals, Inc. | Abandoned -- Incomplete Application (Pre-examination) | Lorianne K. Masuoka Jaakko Lappalainen | United States United States | ||
| 2021-12-06 | 17543094 | Intravenous Ganaxolone Formulations and Methods of Use in Treating Status Epilepticus and Other Seizure Disorders | MARINUS PHARMACEUTICALS, INC. | Abandoned -- Incomplete Application (Pre-examination) | Mingbao ZHANG Raymond C. GLOWAKY | United States United States | ||
| 2021-07-06 | 17368602 | GANAXOLONE FOR USE IN TREATING GENETIC EPILEPTIC DISORDERS | Marinus Pharmaceuticals, Inc. | Abandoned -- Incomplete Application (Pre-examination) | Lorianne K. Masuoka Jaakko Lappalainen | United States United States |